XPhos Pd G1

CAS: 1028206-56-5

Ref. 3D-FX64703

Produktinformation

• Name: XPhos Pd G1
• Synonyme: Palladium, [2-(2-aminoethyl)phenyl]chloro-, compd. with dicyclohexyl[2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine (1:1), (2-Dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl)[2-(2-aminoethyl)phenyl]palladium(ii) chloride, Chloro(2-Dicyclohexylphosphino-2',4',6'-Triisopropyl-1,1'-Biphenyl)[2-(2-Aminoethyl)Phenyl]Palladium(Ii), Chloro(2-dicyclohexylphosphino-2',4',6'-tri-i-propyl-1,1'-biphenyl)[2-(2-aminoethyl)phenyl]palladium(II)methyl-t-butylether adduct, XPhos Palladacycle

Beschreibung

XPhos Pd G1 is a compound that has been synthesized for the treatment of neuroinflammatory, autoimmune, cardiovascular, and cancer disorders. This drug also acts as a nociceptive agent and has been shown to be effective in treating inflammatory pain. XPhos Pd G1 is an insoluble solid that can be prepared by cross-coupling reactions of imidazole derivatives with dioxane. It has been shown to have anti-infectious properties against bacteria and viruses including influenza A, respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and hepatitis B. XPhos Pd G1 also has metabolic effects on the body by reducing levels of pyridine compounds and increasing pyrazolyl concentrations in the blood stream.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 842.22 g/mol
• Formel: C₄₁H₅₉CINPPd
• Reinheit: Min. 95%